Biotech Values

[DewDiligence]

FDA Approves Lyrica for Fibromyalgia

[Lyrica, the successor to PFE’s Neurontin, was already approved for neuropathic pain and epileptic seizure prevention.]

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20070621:MTFH00801_2...

>>
Thu Jun 21, 2007 4:53 PM ET

WASHINGTON, June 21 (Reuters) - Pfizer Inc. <PFE> won approval to promote the prescription drug Lyrica for treating fibromyalgia, U.S. health officials said on Thursday.

The medicine is the first approved drug treatment for the chronic disease which can cause debilitating pain and tenderness, sleep problems, stiffness and fatigue.

…The approval is an important advance for fibromyalgia "and provides a reason for optimism for the many patients who will receive pain relief with Lyrica," Dr. Steven Galson, director of FDA's Center for Drug Evaluation and Research, said in a statement.

"However, consumers should understand that some patients did not experience benefit in clinical trials. We still have more progress to make for treatment of this disorder," he added.
<<